Viking Global Investors’s Trevi Therapeutics TRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.44M | Sell |
1,543,000
-1,684,792
| -52% | -$9.22M | 0.02% | 81 |
|
|
2025
Q1 | $20.3M | Sell |
3,227,792
-1,172,208
| -27% | -$7.37M | 0.06% | 84 |
|
|
2024
Q4 | $18.1M | Hold |
4,400,000
| – | – | 0.06% | 83 |
|
|
2024
Q3 | $14.7M | Hold |
4,400,000
| – | – | 0.05% | 80 |
|
|
2024
Q2 | $13.1M | Hold |
4,400,000
| – | – | 0.05% | 81 |
|
|
2024
Q1 | $15.2M | Hold |
4,400,000
| – | – | 0.06% | 80 |
|
|
2023
Q4 | $5.9M | Hold |
4,400,000
| – | – | 0.02% | 78 |
|
|
2023
Q3 | $9.59M | Hold |
4,400,000
| – | – | 0.04% | 76 |
|
|
2023
Q2 | $10.5M | Hold |
4,400,000
| – | – | 0.04% | 83 |
|
|
2023
Q1 | $8.14M | Hold |
4,400,000
| – | – | 0.04% | 77 |
|
|
2022
Q4 | $8.49M | Hold |
4,400,000
| – | – | 0.04% | 73 |
|
|
2022
Q3 | $6.78M | Buy |
+4,400,000
| New | +$6.78M | 0.03% | 88 |
|